Adenovirus-mediated gene transfer into injured arteries: Quantitative analysis of repeated administration

Gerontology

Volumn 42, Issue 1, 1996, Pages 25-36

  Ueno, Hikaru ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Balloon injury; Gene therapy; In vivo arterial gene transfer; Recombinant adenovirus; Repetitive infection

Indexed keywords

BETA GALACTOSIDASE;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY MUSCLE; BALLOON CATHETER; CONFERENCE PAPER; DOG; FEMALE; FEMORAL ARTERY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSGENE;

ADENOVIRIDAE; ANIMALS; ARTERIES; BALLOON DILATATION; DOGS; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; IMMUNIZATION; LAC OPERON; MALE; POLYMERASE CHAIN REACTION;

EID: 0029989656     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000213822     Document Type: Article

References (45)

1. Lcmarchand P, Ari Jaffe H, Dancl C, Cid MC, Kleinman HK, Strat-ford-Perricaudct LD, Pcrricaudet M, Pavirani A, Lecocq J-P, Crystal RG: Adenovirus-mediated transfer of a recombinant human al-anti-trypsin cDNA to human endothelial cells. Proc Natl Acad Sei USA 1992; 89:6482-6486.
2. Feldman ST, Gjerset R, Gately D, Chien KR, Feramisco JR: Expression of SV 40 virus large T antigen by recombinant adenoviruses activates proliferation of corneal endothelium in vitro. J Clin Invest 1993; 91:1713-1720.
3. Guzman RJ, Lemarchand P, Crystal RG, Epstein SE, Finkel T: Efficient and selective adenovirus-mediated gene transfer into vascular neointi-ma. Circulation 1993:88:2838-2848.
4. Lee SW, Trapnell BC, Rade JJ, Virmani R, Dichek DA: In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res 1993;73:797-807.
5. Lemarchand P, Jones M, Yamada I, Crystal RG: In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res 1993:72:1132-1138.
6. Chen S-J, Wilson JM, Muller DWM: Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Circulation 1994: 89:1922-1928.
7. French BA, Mazur W, Ali NM, Geske RS, Finnigan JP, Rodgers GP, Roberts R, Raizner AE: Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary rcstenosis. Circulation 1994:90:2402-2413.
8. Gabriel Steg P, Feldman U, Scoa-zee J-Y, Tahlil O, Barry JJ, Boulechfar S, Ragot T, Isner JM, Perricaudet M: Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector. Circulation 1994;90:1648-1656.
9. Ohno T, Gordon D, San H, Pompili VJ, Imperiale MJ, Nabel GJ, Nabel EG: Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 1994:265: 781-784.
10. Rome JJ, Shayani V, Flugelman MY, Newman KD, Farb A, Virmani R, Dichek DA: Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Artcrioscler Thromb 1994; 14:148-161.
11. Rome JJ, Shayani V, Newman KD, Farrell S, Lee SW, Virmani R, Dichek DA: Adenoviral vector-mediated gene transfer into sheep arteries using a double-balloon catheter. Hum Gene Ther 1994,5:1249-1258.
12. Willard JE, Landau C, Glamann B, Bums D, Jessen ME, Pirwitz MJ, Gerard RD, Meidell RS: Genetic modification of the vessel wall: Comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus. Circulation 1994;89:2190-2197.
13. Chang MW, Barr E, Seltzer J, Jiang Y-Q, Nabel GJ, Nabel EG, Parmacek MS, Leiden JM: Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 1995,267:518-522.
14. Li J-J, Ueno H, Tomita H, Yamamoto H, Kanegae Y, Saito I, Takeshita A: Adenovirus-mediated arterial gene transfer does not require prior injury for submaximal gene expression. Gene Ther 1995:2:351-354.
15. Graham FL, Smiley J, Russell WC, Naim R: Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977;36:59-72.
16. Saito I, Oya Y, Yamamoto K, Yuasa T, Shimojo H: Construction of non-defect ivc adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome. J Virol 1985;54:711-719.
17. Li J-J, Ueno H, Pan Y, Tomita H, Yamamoto H, Kanegae Y, Saito I, Takeshita A: Percutaneous transluminal gene transfer into canine myocardium in vivo by replication-defective adenovirus. Cardiovasc Res 1995;30:97-105.
18. Ueno H, Li J-J, Tomita H, Yamamoto H, Pan Y, Kanegae Y, Saito I, Takeshita A: Quantitative analysis of repeated adenovirus-mediated gene transfer into injured canine femoral arteries. Arteriosel Thromb Vase Biol 1995;in press.
19. Niwa H, Yamamura K, Miyazaki J: Efficient selection for high-cxpres-sion transfectants with a novel eukaryotic vector. Gene 1991; 108:193-200.
20. Takebe Y, Seiki M, Fujisawa J, Hoy P, Yokota K, Arai K, Yoshida M. Arai N: SRa promoter: An efficient and versatile mammalian cDNA expression system composed of the simian vims 40 early promoter and the R-U5 segment of human T-cell leukemia vims type 1 long terminal repeat. Mol Cell Biol 1988;8:466-472.
21. Eustice DC. Feldman PA. Colberg-Polev AM, Buckery RM, Neubauer RH: A sensitive method for the detection of β-galactosidase in transfected mammalian cells. BioTcchni-ques 1991;11:739-742.
22. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976:72: 248-254.
23. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor. Cold Spring Harbor Laboratory Press. 1989.
24. Dupree P, Olkkonen VM, Chavrier P: Sequence of a canine cDNA clone encoding a Ran/TC4 GTP-binding protein. Gene 1992:120:325-326.
25. Barbee RW, Stapleton DD, Perry BD, Re RN, Murgo JP, Valentino VA, Cook JL: Prior arterial injury enhances luciferase expression following in vivo gene transfer. Biochem Biophys Res Commun 1993; 190:70-78.
26. Engelhardt JF, Yang Y, Stradford-Perricaudel LD, Allen ED, Kozarsky K, Perricaudet M, Yankaskas JR, Wilson JM: Direct gene transfer of human CFTR into human bronchial epilhclia of xenografts with El-deleted adenoviruses. Nature Genet 1993;4:27-34.
27. Rich DP, Couture LA, Cardoza LM, Guiggio VM, Armentano D, Espino PC, Hehir K, Welsh MJ, Smith AE, Gregory RJ: Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis. Hum Gene Ther 1993:4:461-476.
28. Hertz J, Gerard RD: Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA 1993;90:2812-2816.
29. French BA, Mazur W, Geske RS, Bolli R: Direct in vivo gene transfer into porcine myocardium using re-plication-deficient adenoviral vectors. Circulation 1994:90:2414-2424.
30. Mittal SK, McDermott MR, Johnson DC, Prevec L, Graham FL: Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res 1993:28:67-90.
31. Kass-Eisler A, Falck-Pederson E, El-fenbein DH, Alvira M, Buttrick PM, Leinwand LA: The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther 1994;1:395-402.
32. Setoguchi Y, Jaffe HA, Chu C-S, Crystal RG: Intrapcritoneal in vivo gene therapy to deliver al-antitryp-sin to the systemic circulation. Am J Resp Cell Mol Biol 1994:10:369-377.
33. Yei S, Mittereder N, Tang K, O’Sullivan C, Trapnell BC: Adenovirus-mediated gene transfer for cystic fibrosis: Quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther 1994; 1: 192-200.
34. Simon RH, Engelhardt JF, Yang Y, Zepeda M, Weber-Pendlelon S, Grossman M, Wilson JM: Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum Gene Ther 1993;4:771-780.
35. Yang Y, Nunes FA, Berenesi K, Furth EE, Gonezol E, Wilson JM: Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994;91:4407-4411.
36. Yei S, Mittereder N, West S, Whitsett JA, Wilmott RW, Trapnell BC: In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum Gene Ther 1994:5: 733-746.
37. Barr E, Carroll J, Kalynych AM, Tripathy SK, Kozarsky K, Wilson JM, Leiden JM: Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther 1994;1:51-58.
38. Bout A, Imler J-L, Schultz H, Perricaudet M, Zureher C, Herbrink P, Valerio D, Pavirani A: In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: efficacy, toxicity and safety. Gene Ther 1994; 1:385-394.
39. Muller DWM, Gordon D, San H, Yang Z, Pompili VJ, Nabel GJ, Nabel EG: Catheter-mediated pulmonary vascular gene transfer and expression. Circ Res 1994;75:1039-1049.
40. Zabner J, Petersen DM, Puga AI, Graham SM. Couture LA, Keyes LD, Lukason MJ, St George JA, Gregory RJ, Smith AE, Welsh MJ: Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nature Genet 1994;6:75-83.
41. Rowe WP, Huebner RJ, Hartley JW, Ward TG, Parrot RH: Studies of the adenoidal-pharyngeal-con-junctivial group of viruses. Am J Hyg 1955:61:197-218.
42. Engelhardt JF, Litzky L, Wilson JM: Prolonged transfcnc expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum Gene Ther 1994;5:1217-1229.
43. Engelhardt JF, Ye X, Doranz B, Wilson JM: Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 1994; 91:6196-6200.
44. Yang Y, Nunes FA, Berenesi K, Gonezol E, Engelhardt JR, Wilson JM: Inactivation of E2a in recombinant adenoviruses limits cellular immunity and improves the prospect for gene therapy of cystic fibrosis. Nature Genet 1994;7:362-369.
45. Lee MG, Abina MA, Haddada H, Perricaudet M: The constitutive expression of the immunomodulatory gp 19k protein in EU, E3- adenoviral vectors strongly reduced the host cytotoxic T cell response against the vector. Gene Ther 1995;2:256-262.